Equivalence of the 3-month and 28-day formulations of triptorelin with regard to achievement and maintenance of medical castration in women with endometriosis
article
OA: closed
CC0
⤵ 8 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This study assessed whether the 3-month and 28-day triptorelin formulations were equivalent in achieving and maintaining medical castration in women diagnosed with endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (31)
- 9 Endometriosis: Medical therapy via openalex
- A randomized, comparative trial of triptorelin depot (D-Trp6-LHRH) and danazol in the treatment of endometriosis via openalex
- Aromatase as a Therapeutic Target in Endometriosis via openalex
- Dosage aspects of danazol therapy in endometriosis. via openalex
- Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectiveness via openalex
- Effects of Triptorelin Versus Placebo on the Symptoms of Endometriosis via openalex
- Extracts from "Clinical Evidence": Endometriosis via openalex
- Laparoscopic treatment of symptomatic endometriosis via openalex
- Large ovarian endometriomas via openalex
- Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. via openalex
- [Pelvic pain and external endometriosis. Physiopathology and treatment]. via openalex
- Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities via openalex
- Status of current research on endometriosis. via openalex
- Surgical treatment and adjunct therapy of endometriosis. via openalex
- The efficacy of medical and surgical treatment of endometriosis-associated infertility: arguments in favour of a medico-surgical aproach via openalex
- The place of GnRH agonists in the treatment of endometriosis and fibroids by advanced endoscopic techniques via openalex
- Therapeutic hypogonadism induced by a delayed-release preparation of microcapsules of D-Trp-6-luteinizing hormone-releasing hormone: a preliminary study in eight women with endometriosis. via openalex
- Today's treatments: medical, surgical and in partnership via openalex
- Treatment of Endometriosis via openalex
- Treatment of Severe Postmenopausal Endometriosis With an Aromatase Inhibitor via openalex
- Use of nafarelin versus placebo after reductive laparoscopic surgery for endometriosis via openalex
- W187836676 via openalex
- W6600459291 via openalex
- W6718210757 via openalex
- W2154095911 via openalex
- W2172084418 via openalex
- W2213786061 via openalex
- W1976065233 via openalex
- W2318326562 via openalex
- W2322133447 via openalex
- W2407529019 via openalex
Cited by (8)
- A systematic literature review on patient-reported outcome domains and measures in nonsurgical efficacy trials related to chronic pain associated with endometriosis: an urgent call to action 2024
- Gonadotropin-releasing hormone analogues for endometriosis 2023
- Mitigating the economic burden of GnRH agonist therapy for progestogen-resistant endometriosis: why not? 2023
- Assessment of Two Formulations of Triptorelin in Chinese Patients with Endometriosis: A Phase 3, Randomized Controlled Trial 2022
- Triptorelin for the treatment of endometriosis 2014
- Gonadotrophin-releasing hormone analogues for pain associated with endometriosis 2010
- Modes of application of gonadotropin-releasing hormone agonists for endometriosis treatment 2006
- Advances in the management of endometriosis: an update for clinicians 2005
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:12:38.158000+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK